Full Text View
Tabular View
No Study Results Posted
Related Studies
HER-2 Protein Vaccine in Treating Women With Breast Cancer
This study has been completed.
Study NCT00068614   Information provided by National Cancer Institute (NCI)

First Received on September 10, 2003.   Last Updated on February 12, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
HER-2/neu peptide vaccine
Sponsors listed in this trial
University Hospitals Seidman Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services